F
Live / Applied — Fourth extension granted (statement of use) (as of 31 Jul 2025)
What this means for you
Not registered yet, but its 14 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97676154
- Mark type
- Word mark
- Filed
- 14 Nov 2022
- Published for opposition
- 11 Jul 2023
- Attorney of record
- LEIGH ANN LINDQUIST
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of hyperuricemia and gout
Owner
- Teijin Pharma Limited, Chiyoda-ku, Tokyo, JP
- Teijin Pharma Limited, Chiyoda-ku, Tokyo, JP
Prosecution history
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Jul 2025 — SOU EXTENSION 4 GRANTED
- 31 Jul 2025 — SOU EXTENSION 4 FILED
- 31 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Feb 2025 — SOU EXTENSION 3 GRANTED
- 10 Feb 2025 — SOU EXTENSION 3 FILED
- 10 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Aug 2024 — SOU EXTENSION 2 GRANTED
- 09 Aug 2024 — SOU EXTENSION 2 FILED
- 09 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2024 — SOU EXTENSION 1 GRANTED